Germany-headquartered Bayer (ETR: BAYN) has announced a strategic partnership with US digital developer Mahana Therapeutics. The collaboration focuses on the distribution and marketing of Mahana’s digital technologies, further expanding Bayer’s foray into the digital health sector. This move follows Bayer’s launch earlier this year of a precision health product development segment aimed at tech-savvy consumers seeking drug-free treatment options.
A Significant Investment in the Digital Health Sector
While the financial specifics of the partnership were not disclosed, the press release indicated that the deal is valued in the millions of USD. The investment is highlighted as one of the first major forays by a global life sciences company into the digital health sector, signaling a significant commitment to integrating digital solutions into healthcare.-Fineline Info & Tech
